9.69
price down icon8.93%   -0.95
pre-market  Vorhandelsmarkt:  9.89   0.20   +2.06%
loading
Schlusskurs vom Vortag:
$10.64
Offen:
$10.59
24-Stunden-Volumen:
954.82K
Relative Volume:
1.61
Marktkapitalisierung:
$682.78M
Einnahmen:
$133.62M
Nettoeinkommen (Verlust:
$-177.37M
KGV:
-3.3529
EPS:
-2.89
Netto-Cashflow:
$23.50M
1W Leistung:
-18.02%
1M Leistung:
-36.91%
6M Leistung:
-50.66%
1J Leistung:
-55.79%
1-Tages-Spanne:
Value
$9.65
$10.59
1-Wochen-Bereich:
Value
$9.65
$12.04
52-Wochen-Spanne:
Value
$9.65
$27.24

Xencor Inc Stock (XNCR) Company Profile

Name
Firmenname
Xencor Inc
Name
Telefon
626-305-5900
Name
Adresse
465 N. HALSTEAD ST., PASADENA, CA
Name
Mitarbeiter
250
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
XNCR's Discussions on Twitter

Vergleichen Sie XNCR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
XNCR
Xencor Inc
9.69 682.78M 133.62M -177.37M 23.50M -2.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Xencor Inc Stock (XNCR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-12 Eingeleitet Wells Fargo Overweight
2024-12-02 Hochstufung Piper Sandler Neutral → Overweight
2024-04-16 Bestätigt BTIG Research Buy
2024-02-28 Herabstufung Piper Sandler Overweight → Neutral
2023-05-19 Eingeleitet BofA Securities Buy
2022-12-06 Eingeleitet Cowen Outperform
2022-10-13 Hochstufung Raymond James Outperform → Strong Buy
2022-09-21 Eingeleitet JP Morgan Overweight
2022-07-06 Fortgesetzt Canaccord Genuity Buy
2022-02-11 Eingeleitet BMO Capital Markets Outperform
2022-01-21 Eingeleitet SMBC Nikko Outperform
2021-12-15 Eingeleitet H.C. Wainwright Buy
2021-10-15 Fortgesetzt BTIG Research Buy
2021-02-24 Hochstufung Raymond James Mkt Perform → Outperform
2020-03-04 Eingeleitet Barclays Underweight
2020-02-25 Hochstufung Guggenheim Neutral → Buy
2020-01-30 Eingeleitet RBC Capital Mkts Outperform
2019-11-20 Fortgesetzt Guggenheim Neutral
2019-08-07 Herabstufung Guggenheim Buy → Neutral
2019-08-07 Herabstufung Raymond James Outperform → Mkt Perform
2019-06-13 Eingeleitet Mizuho Buy
2019-04-12 Eingeleitet Guggenheim Buy
2019-03-27 Eingeleitet Berenberg Buy
2019-03-15 Eingeleitet Raymond James Outperform
2018-09-10 Fortgesetzt BTIG Research Buy
2018-03-28 Fortgesetzt Leerink Partners Outperform
2017-03-02 Eingeleitet Instinet Neutral
2017-03-02 Bestätigt Wedbush Outperform
2016-10-04 Eingeleitet Piper Jaffray Overweight
2015-12-22 Eingeleitet Canaccord Genuity Buy
2015-08-05 Bestätigt MLV & Co Buy
2015-02-12 Bestätigt Oppenheimer Outperform
2015-01-28 Bestätigt MLV & Co Buy
2014-07-11 Eingeleitet Oppenheimer Outperform
Alle ansehen

Xencor Inc Aktie (XNCR) Neueste Nachrichten

pulisher
Apr 01, 2025

Teacher Retirement System of Texas Has $428,000 Stock Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Apr 01, 2025
pulisher
Mar 30, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely - simplywall.st

Mar 30, 2025
pulisher
Mar 30, 2025

Raymond James Financial Inc. Acquires New Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 30, 2025
pulisher
Mar 27, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares Bought by Swiss National Bank - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

PNC Financial Services Group Inc. Raises Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Xencor stock touches 52-week low at $12.53 amid market challenges By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

Xencor stock touches 52-week low at $12.53 amid market challenges - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

When (XNCR) Moves Investors should Listen - news.stocktradersdaily.com

Mar 24, 2025
pulisher
Mar 21, 2025

Charles Schwab Investment Management Inc. Boosts Stock Holdings in Xencor, Inc. (NASDAQ:XNCR) - Armenian Reporter

Mar 21, 2025
pulisher
Mar 21, 2025

Charles Schwab Investment Management Inc. Purchases 3,652 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Amundi Acquires 24,494 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

US Bancorp DE Reduces Stock Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 19, 2025
pulisher
Mar 14, 2025

Bank of New York Mellon Corp Purchases 18,586 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Federal Circuit Rules Jepson Claims Need Full Written Description: Another Nail in the Coffin - Patently-O

Mar 14, 2025
pulisher
Mar 14, 2025

Xencor (NASDAQ:XNCR) Stock Rating Lowered by StockNews.com - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Fed. Circ. Dings Antibody Patent App For Lacking Description - Law360

Mar 13, 2025
pulisher
Mar 13, 2025

Xencor Appoints Todd Simpson To Board Of Directors -March 13, 2025 at 05:31 pm EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

Xencor Appoints Todd Simpson to Board of Directors - sharewise.com

Mar 13, 2025
pulisher
Mar 13, 2025

Xencor Strengthens Board with Veteran Biotech CFO Behind Seagen's Multi-Billion Success - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Xencor CEO Dahiyat sells $268,080 in common stock - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

Xencor’s EVP Nancy Valente sells $34,876 in stock By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 12, 2025

Antibody Humanization Market Critical Analysis with Expert Opinion: Genentech, Adimab, Xencor - openPR

Mar 12, 2025
pulisher
Mar 12, 2025

Xencor Sr. vice president sells $131,851 in shares By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Xencor’s SVP sells $78,047 in stock By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 11, 2025

Xencor stock touches 52-week low at $13.2 amid market challenges - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

Xencor’s SVP sells $78,047 in stock - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Xencor’s EVP Nancy Valente sells $34,876 in stock - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

Xencor CEO Dahiyat sells $268,080 in common stock By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Xencor Executives Sell Shares to Cover Taxes - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Xencor stock touches 52-week low at $13.2 amid market challenges By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Mutual of America Capital Management LLC Buys Shares of 10,600 Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

Xencor, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Top Premarket Gainers -March 07, 2025 at 07:34 am EST - Marketscreener.com

Mar 07, 2025
pulisher
Mar 06, 2025

Xencor (NASDAQ:XNCR) Upgraded by StockNews.com to “Hold” Rating - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

How does Xencor Inc (XNCR) change from a tortoise to a hare? - SETE News

Mar 05, 2025
pulisher
Mar 05, 2025

Xencor, Inc. (NASDAQ:XNCR) Stake Increased by Amalgamated Bank - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Xencor stock touches 52-week low at $14.16 amid market challenges - Investing.com

Mar 05, 2025
pulisher
Mar 04, 2025

Examining the Potential Price Growth of Xencor Inc (XNCR) - Knox Daily

Mar 04, 2025
pulisher
Mar 04, 2025

Xencor stock touches 52-week low at $14.16 amid market challenges By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 03, 2025

Xencor, Inc. (NASDAQ:XNCR) Receives $34.88 Consensus Target Price from Analysts - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

(XNCR) Technical Data - Stock Traders Daily

Mar 03, 2025
pulisher
Mar 02, 2025

Principal Financial Group Inc. Grows Stock Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 02, 2025
pulisher
Mar 02, 2025

Wells Fargo & Company Issues Pessimistic Forecast for Xencor (NASDAQ:XNCR) Stock Price - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Xencor, Inc. (NASDAQ:XNCR) Stake Raised by Rhumbline Advisers - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Sanctuary Advisors LLC Raises Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 01, 2025

Finanzdaten der Xencor Inc-Aktie (XNCR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
Kapitalisierung:     |  Volumen (24h):